Price Reporting Mechanism (PRM): Lessons learnt and how to use the evidence from the PRM Technical Briefing Seminar for Consultants on Procurement and.

Slides:



Advertisements
Similar presentations
Saul Walker Policy and Research Division, DFID Jordan 4 December, 2007 Medicines Transparency Alliance (MeTA)
Advertisements

2 nd line and recent ARVs prices and access issues Carmen Pérez Casas Access Campaign MSF May 2006.
Advocacy Campaign ICP Farah Hussain
EasyDirector® Simplifying the way you manage your business... Full-Featured Contact & Customer Relationship Management Tool Prepared by AITechConsulting.
Quality Assurance Processes for TB Drugs. GDF Quality Assurance Processes.
Desk Study for AIDS Medicines and Diagnostic Services October 10, 2005.
PROCURING AND DISTRIBUTING ARVs AND OTHER A.R.T COMMODITIES IN MALAWI Technical Briefing for Consultants in Procurement and Supply Management for HIV,
Group III: Demand Forecasting
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
National PSM Coordination Mechanism Dr Vincent Habiyambere WHO/HIV Department AIDS Medicines & Diagnostics Service (AMDS) Bangkok, July 2005.
AMDS Contribution to the Technical Briefing Seminar October 2007.
Multiple Indicator Cluster Surveys Survey Design Workshop MICS Technical Assistance MICS Survey Design Workshop.
THE INTERNATIONAL DRUG PURCHASE FACILITY-UNITAID Michel D. Kazatchkine, Ministère des Affaires Etrangères, France.
Improving the quality of data in the Global Price Reporting Mechanism for a reliable market intelligence project International Multi-stakeholder Consultation.
Public ARV Procurement Data: Using Information to Obtain Lower Prices Brenda Waning March 6, 2008 Open Society Institute Seminar Kiev, Ukraine Funded by.
1 Adoption of nutrition policies with implementation of nutrition actions in health and other sectors …and collects information on lessons learnt GINA.
WHO update on: Guidelines for the selection of RH medicines and prequalification of priority RH medicines Medicines Policy and Standards Health Technology.
Promoting patient-centred healthcare around the world Advancing the fight against counterfeit medicines Ms. Regina Kamoga IAPO Board Member, Country Manager,
Policy on Quality Assurance for Single and Limited- Source Pharmaceuticals Nairobi, Kenya, 20 – 24 February 2006.
World Health Organization
B2Bdatapartners Website : | Phone : |
WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies
Chapter 3 Database Management
Current Surveys of Wholesale and Retail Trade An Overview of the Wholesale and Retail Programs Timothy Winters Service Sector Statistics Division 17 June.
Update by IDA Foundation Leontien Ruttenberg MSc MBA.
Access to HIV/AIDS, Tuberculosis and Malaria Medicines. WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies. Geneva, 18 – 22 September.
Measles Partnership Meeting Yalda Momeni September 23 rd - WDC.
UNITAID’s Market Approach in HIV Diagnostics Brenda Waning International AIDS Society 18 July, 2011 Rome.
One SADC, One Vision, One Way Working Together Towards MDG 6: SADC’s Common Vision Hon. Benedict Xaba, Minister of Health of Swaziland International AIDS.
PROCUREMENT SUPPORT SERVICE WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November 1 st -5 th 2010 Mariatou Tala Jallow, Manager,
Eleventh Edition 1 Introduction to Information Systems Essentials for the Internetworked E-Business Enterprise Irwin/McGraw-Hill Copyright © 2002, The.
Using the levy in order to finance recurring expenditures : the case of the International Drug Purchase Facility-UNITAID Meeting of experts on the solidarity.
Update and future directions for prequalification of medicines WHO HQ, Geneva, 4 February 2008 Dr Lembit Rägo Coordinator Quality Assurance and Safety:
CaLP RCWG – 28 th January 2015 Start time : 3 – 5pm (Thailand) Presenters: Rebecca Vo – CaLP Asia Regional Focal Point Wadel S. Cabrera III – CaLP Asia.
QuickBooks QB i 2009/10 New Features Presented by Helen Goodyear.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
Treating MDR-TB A Challenge Throughout ECA Public Health Practice II.
WHO-HIV Department Strategic Information Unit AIDS Medicines and Diagnostics Service Contribution to Access to medicines Technical Briefing Seminar, November.
1 Introduction to the Clinton Foundation HIV/AIDS Initiative 12 July 2007 Africa Recruit.
From 3by5 to Universal Access to HIV/AIDS Treatment: AMDS Technical Briefing Seminar for Consultants on Procurement and Supply Management for HIV, TB and.
Affordability of HIV/AIDS treatment in developing countries: an analysis of ARV drug price determinants Luis Sagaon Teyssier; Yves Arrighi; Boniface Dongmo.
AIDS Medicines and Diagnostics Services - a network of organizations supporting access to HIV medicines and diagnostics J. Perriëns.
1 SUPPLY DIVISION Procurement and Supply Management Technical Assistance.
TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.
Ellen ‘t Hoen Médecins sans Frontières
Pan American Health Organization 1 PAHO Technology, Healthcare and Research Project of Essential Medicine and Biologicals Linking Technical Cooperation.
Overview of the AMDS Products
World Health Organization "3 by 5" Target Access to HIV/AIDS Medicines The 3x5 strategy WHO/EDM Technical Briefing Seminar.
TBS Meeting Geneva, November 2010 Procurement and Supply Management Policies WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November.
Drug Management of Second-line anti-TB drugs through the Green Light Committee mechanism for programmes funded by the Global Fund to Fight Against AIDS,
WHO Technical Briefing Seminar October 2006 Helen Tata Department of Technical Cooperation for Essential Drugs and Traditional Medicines World Health.
Washington D.C., USA, July 2012www.aids2012.org An advocacy tool: Untangling the Web of Antiretroviral Price Reductions Arax Bozadjian HIV Focused.
Global Beta Cyfluthrin Industry Size, Trends, Segmentation Research 2015 Published: Sep 2015 Single User License: US$ 2800 Corporate User License: US$
Acute Heart Failure - Pipeline Review, H To buy this Report Visit
AMDS Clearing House Dr Jos Perriens Coordinator TCO Unit/HIV, WHO.
Market Research on Global Weight Loss Pills Industry Trends Survey and Prospects Report Published: Apr 2016 Single User License: US $2800 Corporate.
Mints Market Report - Worldwide Industry Analysis
Energy Savings Coatings Consumption Market : International Industry Analysis
Global Hemp Fiber Industry Share and 2021 Forecasts Analysis
Global Morpholine Consumption Market 2016: Industry Trends and Analysis
The price trends of HIV/AIDS medicines: Finding and using data Dr. Perriëns Joseph Coordinator SSH Unit, WHO.
Introduction to SHERPA RoMEO and its Significance for Publishers
SADC Medicines Database (SMD)
Global Cryptocurrency Market (Bitcoin, Ripple, Litecoin, Ethereum)- Insights and Analysis: Technology, Sizing, Growth and Potential Analysis of Cryptocurrency.
GDF Quality Assurance Processes
World Health Organization
World Health Organization
B. Dongmo Nguimfack AMDS TCO Unit/HIV, WHO
AMDS Products, events and issues.
Access to HIV/AIDS Medicines The 3x5 strategy
Presentation transcript:

Price Reporting Mechanism (PRM): Lessons learnt and how to use the evidence from the PRM Technical Briefing Seminar for Consultants on Procurement and Supply Management for HIV, TB and Malaria 30 January 2006 Copenhagen Peter Graaff, AMDS, HIV

2 AMDS

3 AMDS Introduction and Purpose of the GPRM The Global Price Reporting Mechanism is a database that consolidates information (price, volume, …) of ARV drugs Information on other drugs (such as TB or malaria drugs) is included when available but is not actively sought

4 AMDS Background Procurement decision makers should know their potential suppliers and the price they should expect to pay for their products Existing information sources include: "Sources and prices" by UNICEF/WHO/MSF/UNAIDS "Untangling the web" by MSF The GFATM Price Reporting Mechanism Indicative prices announced by procurement organisations (IDA) or foundations (CHAI) With exception of the GFATM Price Reporting Mechanism these information tools record quotes by suppliers and don't record volumes transacted. The GFATM Price Reporting Mechanism has real transaction prices and volumes transacted but Suffers from serious underreporting GFATM represents only part of all transactions

5 AMDS Objectives of the GPRM Put a significant volume of developing country transaction prices of ARVs in the public domain Inform procurement decisions by characterising the different players (suppliers /buyers), their weight in the market and the price they are obtaining/charging Collect essential information to forecast the future of the developing country ARV market

6 AMDS Outcomes: 1) Process Cooperation of main partners (GFATM, UNICEF, IDA, CPS) secured Cooperation of secondary partners (MSH, JSI, Clinton Foundation CHAI, Crown Agents, CHMP) secured and growing No negative feedback from big pharmaceutical companies, positive feedback from several generic companies

7 AMDS Outcomes: 2) Products User-friendly web based searchable database developed and online since June 2005 The GPRM is the biggest database of ARVs transaction prices available in the public domain More than USD 160 million of procurement recorded, or about 1/3 of ARV transactions in developing countries FTP protocol enabling main partners to upload data automatically operational Automated report generator operational Quarterly summary report launched

8 AMDS Global price reporting mechanism

9 AMDS Quarterly summary report

10 AMDS Strengths Process Strength Consolidation of WHO's collaboration with significant partner organizations Technical strengths Size, coverage, details and volume of the database Easy access and report generation

11 AMDS Weaknesses The database contains only wholesale price Incoterms are inconsistently reported Sampling bias: most providers of data are rational, cost effective procurement organizations Data verification limited We need country level reporting

12 AMDS 2006 planning for summary report releases Added features: guidance on how to use the information 2 nd Edition Added features: characterization of pricing behavior by company 3rd Edition Added features: PQ/ICH/PICS regulatory status of products; manufacturers' contacts 4th Edition FebMarchAprilMayJanJuneSepAugJulyOctNovDec EBWHAInt Conf on AIDS World AIDS day: 1 Dec.

13 AMDS For further information please visit the AMDS website or send an to